These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 481319)

  • 1. Inapparent infiltrations associated with vindesine administration.
    Dorr RT; Jones SE
    Med Pediatr Oncol; 1979; 6(4):285-8. PubMed ID: 481319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP; Jones SE; Chester A
    Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
    Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
    Cersosimo RJ; Bromer R; Licciardello JT; Hong WK
    Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
    DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A
    Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 9. Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy.
    Kris MG; Pablo D; Gralla RJ; Burke MT; Prestifilippo J; Lewin D
    Cancer Treat Rep; 1984; 68(7-8):1029-31. PubMed ID: 6744336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)].
    Marthé G; Misset JL; de Vassal F; Hayat M; Gouveia J; Machover D; Belpomme D; Schwarzenberg L; Ribaud P; Pico JL; Musset M; Jasmin C; de Luca L
    Nouv Presse Med; 1978 Feb; 7(7):525-8. PubMed ID: 273888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group].
    Niitani H; Furuse K; Fukuoka M; Hasegawa K; Taguchi T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):177-87. PubMed ID: 8311488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 20. A 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions.
    Rahmani R; Barbet J; Cano JP
    Clin Chim Acta; 1983 Mar; 129(1):57-69. PubMed ID: 6851151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.